Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-11-08

FDA Approved: TOLVAPTAN — Supplemental Application (Apotex Corp.)

View source ↗

Summary

FDA approved a supplemental application for tolvaptan by Apotex Corp., indicating a regulatory update to the generic product's approval (such as labeling or man…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • tolvaptan (tolvaptan)

Snippet

SUPPL AP for TOLVAPTAN (TOLVAPTAN)